Neovascular Glaucoma Follow-up
- Author: Jacqueline Freudenthal, MD; Chief Editor: Hampton Roy Sr, MD more...
Further Outpatient Care
- Ophthalmologists should provide long-term follow-up care for patients with neovascular glaucoma (NVG), closely monitoring for any worsening in the patient's condition.
- Intensity of follow-up care is related to the conditions predisposing the patient to the development of NVG (ie, CRVO, diabetic retinopathy).
Complications
- Complications include uncontrolled glaucoma, hyphema, and loss of vision.
Prognosis
- Generally, NVG carries a very guarded prognosis. Prognosis is highly dependent on the following 2 factors: prevention and treatment of NVG early in its course and the underlying disease process.
Patient Education
- Patients with NVG must be educated about the disease process and its poor prognosis.
- For excellent patient education resources visit eMedicine's Glaucoma Center and Diabetes Center. Also, see eMedicine's patient education articles Glaucoma Overview, Glaucoma FAQs, Understanding Glaucoma Medications, and Diabetic Eye Disease.
Matsui N, Kamao T, Azumi A. [Case of metastatic intraocular malignant lymphoma with neovascular glaucoma]. Nippon Ganka Gakkai Zasshi. Jul 2005;109(7):434-9. [Medline].
Bellotti A, Labbe A, Fayol N, El Mahtoufi A, Baudouin C. [OCT and neovascular glaucoma]. J Fr Ophtalmol. Jun 2007;30(6):586-91. [Medline].
The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. Oct 1995;102(10):1434-44. [Medline].
Hasanreisoglu M, Weinberger D, Mimouni K, Luski M, Bourla D, Kramer M, et al. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma. Eur J Ophthalmol. Jul-Aug 2009;19(4):607-12. [Medline].
Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. Nov 2007;18(6):502-8. [Medline].
Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2009;3.
Ishibashi S, Tawara A, Sohma R, Kubota T, Toh N. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection. Arch Ophthalmol. Dec 2010;128(12):1539-45. [Medline].
Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. May 2008;28(5):696-702. [Medline].
Martinez-Carpio PA, Bonafonte-Marquez E, Heredia-Garcia CD, Bonafonte-Royo S. [Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review]. Arch Soc Esp Oftalmol. Oct 2008;83(10):579-88. [Medline].
Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. Sep 2008;115(9):1571-80, 1580.e1-3. [Medline].
Lee SJ, Lee JJ, Kim SY, Kim SD. Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome. Korean J Ophthalmol. Jun 2009;23(2):132-4. [Medline].
Kotecha A, Spratt A, Ogunbowale L, et al. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series. Arch Ophthalmol. Feb 2011;129(2):145-50. [Medline].
Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. May 2009;147(5):912-8, 918.e1. [Medline].
Luke J, Luke M, Grisanti S. [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery]. Ophthalmologe. May 2009;106(5):407-12. [Medline].
Gupta V, Jha R, Rao A, Kong G, Sihota R. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Eur J Ophthalmol. May-Jun 2009;19(3):435-41. [Medline].
Falavarjani KG, Modarres M, Nazari H. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye (Lond). May 1 2009;[Medline].
Eid TM, Radwan A, el-Manawy W, el-Hawary I. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy. Can J Ophthalmol. Aug 2009;44(4):451-6. [Medline].
Albert DM, Jakobiec FA. Neovascular glaucoma. Principles and Practice of Ophthalmology, Clinical Ophthalmology [book on CD-ROM]. Chapter 215.
Browning DJ, Scott AQ, Peterson CB. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology. May 1998;105(5):776-84. [Medline].
Epstein DL, Allingham RR, Schuman JS. Chandler and Grant's Glaucoma. 4th ed. 1997:309-18.
Gupta V, Agarwal HC. Contact trans-scleral diode laser cyclophotocoagulation treatment for refractory glaucomas in the Indian population. Indian J Ophthalmol. Dec 2000;48(4):295-300. [Medline].
Lieberman MF, Ewing RH. Drainage implant surgery for refractory glaucoma. Int Ophthalmol Clin. Summer 1990;30(3):198-208. [Medline].
Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. May 2009;93(5):589-93. [Medline].
Muller VA, Ruokonen P, Schellenbeck M, et al. Treatment of rubeosis iridis with photodynamic therapy with verteporfin--A new therapeutic and prophylactic option for patients with the risk of neovascular glaucoma?. Ophthalmic Res. Jan-Feb 2003;35(1):60-4. [Medline].
Parodi MB, Iacono P. Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. Am J Ophthalmol. Jul 2004;138(1):157-8. [Medline].
Schlote T, Derse M, Rassmann K. Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma. Aug 2001;10(4):294-301. [Medline].
Shields MB. Textbook of Glaucoma. 4th ed. 1998:269-86.
Sivak-Callcott JA, O'Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. Oct 2001;108(10):1767-76; quiz1777, 1800. [Medline].
Tripathi RC, Li J, Tripathi BJ. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. Feb 1998;105(2):232-7. [Medline].

